Literature DB >> 10493665

Effects of tumor necrosis factor-alpha, interleukin 1beta, and activated peripheral blood mononuclear cells on the expression of adhesion molecules and recruitment of leukocytes in rheumatoid synovial xenografts in SCID mice.

S M Proudman1, L G Cleland, G Mayrhofer.   

Abstract

OBJECTIVE: To examine expression of adhesion molecules within human synovial xenografts in vivo after injection of human cytokines or peripheral blood mononuclear cells (PBMC).
METHODS: Rheumatoid synovium was transplanted into subcutaneous pouches in the ears of severe combined immunodeficient (SCID) mice. Tumor necrosis factor-alpha (TNF-alpha), interleukin 1beta (IL-1beta), or PBMC were injected into the xenografts. The grafts were assessed by immunohistochemistry and quantitative video image analysis.
RESULTS: TNF-alpha, IL-1beta, and concanavalin A activated PBMC increased the expression of vascular cellular adhesion molecule 1 and intercellular adhesion molecule 1 significantly on vessels and nonvascular synovial cells compared with injection of medium only. Vascular expression of E-selectin, but not of MHC Class II, was also increased. These stimuli also induced the migration of murine leukocytes into the xenografts.
CONCLUSION: Rheumatoid synovial xenografts in SCID mice respond by upregulation of adhesion molecule expression when challenged in vivo with proinflammatory cytokines or activated PBMC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493665

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis.

Authors:  Laurie S Davis; Marian Sackler; Ruth I Brezinschek; Ellis Lightfoot; Jennifer L Bailey; Nancy Oppenheimer-Marks; Peter E Lipsky
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  A role for type 1alpha corticotropin-releasing hormone receptors in mediating local changes in chronically inflamed tissue.

Authors:  Jennifer A Ralph; Davide Zocco; Barry Bresnihan; Oliver Fitzgerald; Alice N McEvoy; Evelyn P Murphy
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

Review 3.  Durability and rapidity of response to anakinra in patients with rheumatoid arthritis.

Authors:  Michael H Schiff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Effects of hyaluronic acid conjugation on anti-TNF-α inhibition of inflammation in burns.

Authors:  Emily E Friedrich; Liang Tso Sun; Shanmugasundaram Natesan; David O Zamora; Robert J Christy; Newell R Washburn
Journal:  J Biomed Mater Res A       Date:  2013-06-28       Impact factor: 4.396

5.  Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritis.

Authors:  Lang-Jing Zhu; Lie Dai; Dong-Hui Zheng; Ying-Qian Mo; Xia Ou-Yang; Xiu-Ning Wei; Jun Shen; Bai-Yu Zhang
Journal:  Arthritis Res Ther       Date:  2012-06-04       Impact factor: 5.156

Review 6.  Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies.

Authors:  Katina Schinnerling; Carlos Rosas; Lilian Soto; Ranjeny Thomas; Juan Carlos Aguillón
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

7.  Activation of TGR5 alleviates inflammation in rheumatoid arthritis peripheral blood mononuclear cells and in mice with collagen II‑induced arthritis.

Authors:  Zhe-Yong Li; Jing-Jing Zhou; Chun-Lei Luo; Le-Meng Zhang
Journal:  Mol Med Rep       Date:  2019-09-26       Impact factor: 2.952

8.  Accelerated atherosclerosis in rheumatoid arthritis: a systematic review.

Authors:  Rhea Raj; Sneha Thomas; Vasavi Gorantla
Journal:  F1000Res       Date:  2022-04-27

9.  Mactinin, a fragment of cytoskeletal alpha-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation.

Authors:  Sharon D Luikart; Angela Panoskaltsis-Mortari; Timothy Hinkel; Robert T Perri; Kalpna Gupta; Theodore R Oegema; Pankaj Gupta
Journal:  BMC Cell Biol       Date:  2009-08-28       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.